Round 2
Round 1
Round 2 Projects
VitalTrace
Data Science and Chemistry Applied In-Vivo
About
VitalTrace is a high growth medical device company founded and based in Perth, and currently developing a world-first biosensor aiming at detecting fetal distress during labour. VitalTrace were recently granted Breakthrough Device Designation by the FDA and have a growing team based in Perth and Melbourne.
VitalTrace was founded in 2017 after the founders met during a Stanford Spark Co-Lab and has been driven by raised Seed, Series A and grant funding. Vitaltrace is seeking to usher in a new age of childbirth monitoring, both minimalist in its application and much safer and reliable than current practice.
The team is a thriving, purpose driven MedTech company, striving to improve the way babies are born. Our mission is to develop cutting edge technology to empower all obstetricians and midwives to deliver the greatest outcomes for mothers and babies during labour.
Project
The project spans two business units; Data Science and Chemistry which will work in parallel to explore the application of science in research & development.
For data science, key project outcomes will be the development of BI Dashboards, after conducting relevant in-vivo trials, exploratory data analysis of the in-vivo trial data, assessing ML models and Data Versioning using baseline algorithms for all in-vivo data in parquet format.
Chemistry will cover enzyme assay development, R&D into new formulations and subsequent analysis of the aforementioned activities.
Benefits
Learn More
Claire Li
The University of Western Australia
Biomedical Sciences
Skills: Technical skills in molecular biology, bone biology, cell biology, infectious diseases & biochemistry (qPCR, WB, cell culture, IF, etc), image & data analysis (ImageJ, GraphPad Prism), organisational skills, ability to priorities, attention to detail, communication & interpersonal skills, and teamwork.
Data driven mental health and wellbeing support
Oqea
About
Oqea is the first person-centric mental health and wellbeing digital platform and consumer app to connect consumers, health providers, businesses, family and friends all in one private, safe and secure online place. Oqea is designed to be preventative in nature and empowers people of all walks of life to make healthy connections with helpful people, information, and tools anytime, anywhere, when they need them.
Sadly, there is a growing need for mental health services, with demand far-exceeding supply. The use of technology to support traditional models is growing and with that, the collection of data. Oqea is a digital platform that augments traditional mental health and wellbeing models by providing a person-centred space for care. As a two-sided marketplace, Oqea has a member side that provides a comprehensive place for self-managed or clinician supported care, and a provider side that offers collaborative multidisciplinary care and communication, as well as practice management.
Working on this project students will:
-
Examine and evaluate current data types, sources, and structures within the Oqea platform
-
Identify ways to utilise data driven insights to provide support recommendations to members
-
Identify optimal ways to evaluate and report wellbeing over time
-
Evaluate/identify the cost benefits of digitally supported care
Anticipated outcomes will be in the form of reports and the analysis of a small subset of data from the platform.
Students will get to utilise their skills and work in multi-disciplinary teams to problem solve and gain experience in the digital health industry.
As a company, we will benefit by having research and domain expertise review aspects of the company and provide valuable insights and data to support our mission to enhance the wellbeing of everyone, everywhere.
Emma/Asma Emamrezaei
Curtin University
Public Health
Skills: Design & implementation of economic evaluations (such as cost studies, cost-effectiveness modelling), review of the literature, evaluation and synthesis of the finding for systematic and scoping review, manuscript preparation and publishing, time management, decision-making and goal setting.
Learn More
Benefits
Project
Integrating multiple Loop-mediated Isothermal Amplification (LAMP) assays with multiplexed optical detection systems for ultra-high throughput detection of emerging biosecurity threats
Avicena Systems
Avicena is an award-winning Australian MedTech biosecurity company with a ground-breaking, rapid, pandemic-scale surveillance screening instrument to facilitate the detection of pathogens, including COVID-19. Saliva sampling and anonymous ID tracking takes less than 30 seconds. Each Sentinel instrument can process more than 90,000 samples daily with data available in under 30 minutes.
Project
This project required a combined engineering and molecular biologist team.
Engineering aspect of the project entailed developing optical system solutions involving industrial cameras for the detection and analysis of biochemistry assays using fluorometry in innovative ways for scalable commercial application. Whilst first commercial solution has already been developed for against different targets in customised plates, the new research explored techniques for multiplexing using different wavelengths, different optical techniques and different vision processing algorithms to allow multiple pathogen assays to run in parallel. The engineering involved optical design, electronic application, image processing and software processing, typically within a Python development environment.
Molecular biology aspect of the project involved molecular assay design and development, bioinformatics analysis, data collation and analysis, and critical thinking in experimentation to generate compatible assays for multiplex detection with a high sensitivity and specificity.
Close collaboration with the Avicena's Molecular Diagnostics team and Engineering team supported the project throughout whilst building upon established techniques in place today. It was a great opportunity to apply knowledge in the areas of physics, biochemistry and engineering to solve problems with a true commercial application resulting in high impact on health and biosafety.
Skills
Ideal candidates had the following skillsets.
Engineering team member:
-
Graduate/ completing postgraduate degree in physics or electronics with skills in scientific research and programming
-
Experience in optics will be advantageous
Molecular Diagnostics team member:
-
Completing a PhD in molecular biology or biochemistry with extensive laboratory experience in molecular assays, including PCR and working within a PC2 environment (eg. RNA purification in biosafety cabinet)
-
Bioinformatics and molecular pathology experience are desirable but not essential
Mode
-
3 months placement
-
In-person engagement
Alicia Brunet
The University of Western Australia
Ophthalmology and Visual Science
Skills: Project management (research design, data collection including excel skills, systematic organisation and scheduling), critical thinking & problem solving, lab-based skills (dissection, microscopy, RNA extraction and qRT-PCR, flow cytometry, histology, animal handling and animal behavioural testing & cell/tissue culture).
About
Current and projected market and requirements for wheelchairs in Australia to 2026
Glide
About
Glide is one of Australia's leading manufacturers of high-quality powered and manual wheelchairs. Since the 1970s, our customers have trusted our expertly tailored and solidly constructed chairs for mobility, functionality and comfort. As Australia's largest manufacturer of powered and manual wheelchairs, we continue to collaborate and partner with research organisations to fill the gap to bring an innovative and advanced medical project to commercialisation.
Glide manufactures a range of powered and manual wheelchairs according to Australian Standards, AS3695 – Wheelchairs - Products Requirements and AS3696 – Wheelchairs - Mobility devices for use as seats in motor vehicles, including crash testing certification.
Wheelchairs manufactured by Glide are registered with the Therapeutic Goods Administration (TGA) as a Class One medical device. Glide operations are certified by Compass Assurance to ISO 9001. Glide is currently implementing systems to achieve ISO13485 Medical Device. This standard involves designing, producing, installing, and servicing medical devices and related services. Additionally, Glide is in the process of achieving a net-zero certification of "Climate Active Carbon Neutral" by the Australian Government, including ISO 14001 Environmental Management.
Project
The project will focus on commercial and technical aspects of the Assisted Technology market in Australia.
The project should identify wheelchair users requiring manual, power assist and electric wheelchairs over the coming years. It will involve analysis of the market into users with a disability and users in the aged market. The market for aged users requiring the use of a wheelchair should be segmented based on those requiring a wheelchair in an aged care facility and those requiring use of a wheelchair in an "aging at home" environment. This information can be used by Glide to shape its product offering, enabling the company to play a critical role in helping those in the Australian community needing assistance to maintain mobility and independence.
Benefits
Analyse the desired requirements, both functional and accessories, of a wheelchair to meet the various market segments, which enables manufacture of wheelchairs that are “fit for purpose” to suit the various segments within the aged market. This includes determining the optimal desired weight of a wheelchair to suit the aged market.
Student benefits include an enhanced understand of Australians requiring wheelchairs in Australia. Assisting in design features for a manual wheelchair for elderly Australians to age at home will improve the quality of life for many in need of mobility assistance.
Learn More
Medical Education Unit
Unpacking the (true) cost of medical assessments (entry to exit)
About
Established as the State’s first university in 1911 and founded with a mission to ‘advance the prosperity and welfare of our communities’, the University opened in 1913 to just 184 students. Today, more than 25,000 students are enrolled from 100 countries.
UWA’s Medical School brings together the brightest students, experienced clinicians and committed researchers to unlock the greatest health challenges of our day. Celebrating 60 years in 2017, the Medical School is an infinite source of teaching and learning for individuals who share our goal of delivering better health outcomes today and into the future.
We have a renowned research program carried out in laboratories, hospitals and in the community at a patient level, and we offer a range of scientific and clinical research opportunities across 10 divisions.
Project
Assessment plays a key role in a medical degree. The true cost from entry through to exit is not always transparent to the relevant stakeholders to make informed decisions about assessment decisions throughout the medical degree. The project aims to look at the four-year postgraduate UWA Medical Program and map assessments against costs (human & financial). Progression of students and the cost of failing students will also be reviewed.
Benefits
For this project students will utilise their skills to generate a map of assessments, with human resource, time, financial and estimates of effort in each assessment task across the medical degree. This will greatly benefit us, as assessments can be improved over time to provide greater authentic, work-based learning tasks. Progression of students via various pathways will also be examined and provide greater insight.
Learn More
Sylvester A Obeng-Darko
The University of Western Australia
Biological Science
Skills: Molecular skills (DNA, eDNA, RNA, protein extraction), PCR, ELISA, Microscopy (optical and SEM), physiological assessment, HPLC, RNA-seq analysis, microbial biochemical analysis, statistical analysis & data visualization, report writing and critical review.
Biodegradable materials for plant pots
Veratin
About
Veratin Limited is a publicly listed company (NSX:VTN) developing high value, innovative products from raw waste wool.
In Australia there are over three times as many sheep as people. Australia is a leading grower of wool world-wide, accounting for approximately 25% of the market. However, not all this wool is suitable for the textile industry leaving an abundance of low grade wool with little value.
Veratin works with local farms to purchase low grade wool that appears to have little value. We use green processing to transform this wool into sustainable high value products.
We manufacture and sell our flagship product Verigrow, an amino-acid-rich liquid fertiliser and soil improver, to nurseries, hardware stores, and farms across the country. We are also actively developing products in the cosmetics and nutraceutical space.
Project
Plant pots are overwhelmingly made from non-biodegradable plastic, which contributes to landfill. This project will advance our ambitions of producing a fully biodegradable plant pot that can be planted directly in the ground - providing nutrients to plants and enriching the soil.
Benefits
The project will advance the student’s knowledge of polymer and material chemistry, and contribute to the development and release of environmentally friendly product(s) to the market.
Learn More
Veratin:
https://www.linkedin.com/company/veratin/
https://www.facebook.com/verigrow
Verigrow:
https://www.linkedin.com/company/verigrow/
https://www.facebook.com/verigrow.au
Story on ABC Landline (from 5:21):
Fiona Stanley Fremantle Hospitals Group
PATHFINDER: Improving the path to better health outcomes for people with heart failure
About
Fiona Stanley Hospital is the major tertiary hospital in the south metropolitan area of Perth, and offers a high standard of patient care to communities south of Perth and across the State. A leader in clinical care, research and education, Fiona Stanley Hospital is supported by an innovative design that uses the latest scientific, technological and medical developments to help provide the best possible care for patients. The Advanced Heart Failure and Cardiac Transplant Service at Fiona Stanley Hospital is the specialist state service for the management of patients with heart failure.
Project
Heart failure is a common condition affecting half a million Australians. People with heart failure often get admitted to hospital during periods of ill health. However, many of these hospitalisations are preventable with clinical management that is consistent with evidence-based guidelines.
This project will involve developing a health care solution designed to improve the coordination of care between hospitals and general practice, support GPs in providing care that aligns with guidelines, especially medication prescription, and educate patients about self-management. The solution will also monitor patients remotely based on their weight, because rapid weight increases suggest fluid retention, an early sign that the person is becoming unwell. The intervention will be delivered through a digital health platform accessible to clinicians and patients through separate portals. We anticipate that the provision of best-practice care, and closer patient monitoring, will help keep people out of hospital and enable them to lead healthier, happier and more productive lives.
Skills
Due to the varying components of the project we are seeking researchers from a wide range of backgrounds including, but not limited to;
-
computer science,
-
computer programming,
-
mathematics,
-
website designs,
-
information technology,
-
medicine,
-
nursing,
-
biomedical science and
-
marketing.
Mode
-
3 months placement
-
Combination of remote and in-person engagement
Elisabetta De Simone
Macquarie University
Psychological Sciences
Skills: Data analysis & visualisation (through R, advanced Excel tools & Photoshop), technical writing, editing & word processing (LaTex, SM Word), customer service & support (patients, students, clients), time & project management and team leadership.
Round 1 Projects
Quality Check for Sensor Manufacturing
VitalTrace
About
VitalTrace are developing a new technology that keeps mothers and babies safe during labour and delivery. It provides continuous, accurate data about the baby’s status during labour, which allows Obstetricians to make informed decisions about management, intervening only when necessary and allowing mothers to birth in the most natural way possible.
https://www.vitaltrace.com.au/
Project
The objective of the project is to form a quality check team working in collaboration with VitalTraces in-house sensor production team.
Benefits
Students will gain invaluable insight into applying their specific and general skills developed during their PhDs whilst working in teams to commercial timelines and priorities. They will learn how to balance doing great science with a lean start up methodology. They will practice valuable communications and teamwork skills.
Benefits of this project will include exposing IPREP students to manufacturing processes performed under an ISO 13485 quality management system.
MARWAH
AL-KAABI
University of Western Australia
Human Science
Skills: Research performance and
communication, problem solving, critical thinking, analysing data using Rstudio, data wrangling and visualization using Rstudio, technical laboratory skills, organised, positive, teamworking skills
and hardworking
Digital Asset Management & Improvement
VeinTech
About
VeinTech is a WA medical device company aiming to reduce the failure rate associated with cannulation. Cannulation is the most common invasive medical procedure to draw blood for testing, or for the delivery of medications. Clinicians fail 40% of the time on the first attempt, resulting in one or more reattempts, at considerable stress to the clinician and suffering for the patient. This can be as high as 70% in patients that are hard to cannulate and in children. This equates to 750 million dollars in wasted Australian health care funds annually. Repeated cannulation attempts result in pain and suffering for the patients and stress and frustration for the health care providers. Delays to successful cannulation result in delays in investigation and treatments, resulting in increased morbidity and longer hospital length of stays. Repeated attempts also increase the risk of serious cannula related blood borne infections which carries a significant increase in patient mortality. VeinTech’s solution is the VeinWave – a handheld ultraportable unit specifically designed to assist with visualising veins to target for cannulation. Our device images and displays simplified veins that are suitable for cannulation quickly, safely and easily, significantly improving the chance of first pass success. The device is cost effective, has minimal training requirement and is able to display the deeper veins that are not visible or palpable.
Project
VeinTech is currenty in an exciting stage of development as its product development approaches a clinic ready prototype and end user studies planned at local hospitals in WA. In parallel, VeinTech is raising its first major seed investment to resource the next stages of development and commercialisation, including engaging potential manufacturers, distributors and engaging potential customers and procurement groups. Digital asset management and improvement will be key for these next stages to ensure professionalism, competitiveness and to generate further momentum of the VeinTech brand. iPREP students with the relevant expertise will be assisting in audits, analyses and revamp of VeinTech’s digital assets and will aid in the creation of new digital tools and content for next stages of the company.
Benefits
The student will be exposed to a range of disciplines, including engineering, medicine and business and will have the opportunity to craft VeinTech’s brand around the intricacies of the unmet clinical need, product and strategy. Feedback will be provided directly by the company’s directors and engagement with external stakeholders including investors, advisors and end users will be facilitated. The student will have an opportunity to apply their design thinking to revamp digital content and create new tools for future efforts.
Development of clinical data dashboards and programs for improved data capture and remote monitoring of patients
Emyria
About
Emyria is a clinical stage biotechnology company, developing multiple treatments for unmet needs using real world patient data. Emyria is headquartered in Perth and operates several clinical practices throughout Australia where we care for patients who have been told nothing else works. Backed up by high quality data capture systems, Emyria is progressing research projects, clinical trials, drug development pathways and digital health innovation. Using our Real-World Data model, we are accelerating the drug development process to improve patient outcomes and deliver better clinical care to patients.
Project
To capture high quality clinical data from patients, with the aim of using that data to provide better clinical care, we need systems and process to do this. These include platforms, such as our clinical services system and remote monitoring, smartphone app. To capture data, we need to create programs that prompt patients to provide clinically validated and relevant data – including symptoms and mental health assessments, which are triggered based on a predetermined schedule. Setup of these programs also involves user testing before rollout to ensure that events are triggered when required.
Data from the remote monitoring app and our clinical systems are then fed into our Datahub platform, powered by Palantir’s Foundry platform, for analysis and insight generation. Dashboards need to be created to allow for the flow of data through predetermined analytical workflows, so that insights into individual patients and patient populations can be interrogated and investigated.
Benefits
Students
-
Industry/corporate exposure
-
Digital health and data capture system experience
-
First-hand experience in clinical research studies and their operation
-
Research differences between academia and industry, and how the two can work exceptionally well together
Emyria
-
Continued engagement with the innovation sector in Perth
-
High quality students with a number of exceptional and diverse skills
-
Development of data dashboards and remote monitoring programs for several research studies.
-
Gain insights into our processes and research studies from highly trained, external experts.
Learn More
SANDRA MOORE
Curtin University
Biomedical Science and Pharmacy
Skills: Molecular biology and protein structure, molecular dynamic simulations and analysis using coding languages, bash and python, research skills including literature search and reviews, written and verbal presentation of data, independent problem solving, collaborating and working well together with others
AMMAR SAID ABDULLAH AL-SHEIDI
Curtin University
Mining and Metallurgical Engineering
Skills Decision making. brilliant Researcher. leadership, communication, continuous learner
Metabolic Health Process Mapping for Digital Health
Metabolic Health Solutions
About
Metabolic Health Solutions (MHS) is an integrated medical technology and digital health company, commercialising low cost, metabolic measurement technology to clinically manage obesity, Type 2 Diabetes (T2DM) and other common metabolic disorders. MHS currently has CE, TGA and HSA Certification for its lead technology ECAL, and have early commercial activities in 8 Countries in Europe and Asia, including wholly owned and partner clinics. Through our clinics and international research programmes we are building an evidence-based data set of the efficacy of indirect calorimetry in a clinical setting to better manage obesity and weight-related chronic disease. We are building this knowledge into a digital health platform ENABLE, that will allow health systems and individual practitioners to benefit from this evidence informed data led metabolic lifestyle approach. The large de-identified data footprint will use machine learning and expert analysis to support enhanced care and develop effective clinical and health economic models to reverse this global epidemic of metabolic disease.
Project
MHS previously had an iPREP team answer the question of whether digital health and machine learning was possible to deliver better metabolic health outcomes. That resulted in the company being able to understand how such a system could be developed. As part of a state innovation grant, MHS is finalising an end goal design of the commercial digital technologies to achieve that. This team will map and build the data model to bridge between the clinical practice and commercial deployment as a prelude to full commercialisation of a minimum viable product.
Benefits
The cross functional team will work in the behavioural, allied health, and data science domains to map our clinical model and the data it collects to a ‘data frame’ that can be used in a digital health implementation. This is a necessary step for commercialisation. In particular the quantification of behavioural elements like patient reported outcomes, emotional and attitudinal aspects requires a cross functional team approach.
Learn More
BINGYAN PANG
Curtin University
Allied Health
Skills: Efficient, solution focus, IT competencies, extensive experience
with Microsoft Suite, SAS, Endnote (Web of Knowledge), Articulate 360, and WA Health specific programs (BOSSNET, iClinical Manager, IMPAX, excellent communication skills including written, verbal, and interpersonal.
Using AI to assist in tumour margin assessment & using data to develop a market strategy
OncoRes Medical
About
OncoRes Medical Pty Ltd (‘OncoRes’) is a private company which spun out of The University of Western Australia and The Western Australian Department of Health in October 2016. It is based in Nedlands. OncoRes was founded at the intersection of medicine, science, and humanity to guide the surgical clearance of cancer in breast conserving surgery and eliminate the physical, psychological, and economic burdens associated with repeat operations.
Our novel imaging technology - Quantitative Micro Elastography or ‘QME’ - produces real-time diagnostic quality tissue images with best-in-class sensitivity and specificity at a resolution approaching histology. OncoRes is developing an in-cavity intra-operative imaging system for use during cancer surgery. Our vibrant and energetic team culture promotes curiosity, vision, restlessness and fun. We are committed to doing the best for patients, customers and our company and are constantly looking to the future and finding new ways to make it better. We love working on big challenges and value the contribution of our teammates and collaborators; always looking to celebrate our success.
Project
OncoRes is currently focussed on a range of product development (technical) and market research (commercial) activities, in order to put its innovative technology in the hands of surgeons.
Our device in development implements algorithms to assess tissue for cancerous regions. We are developing a method to train these algorithms with speed and accuracy using newly labelled data.
We are researching the burden of illness for three types of cancer surgery. This involves consolidating and analysing data from a variety of sources, in order to identify clinical needs which can be addressed with OncoRes’ technology. This project will help formulate key insights for the company’s market strategy.
Benefits
-
Industry/corporate exposure
-
Appreciation of differences between academic and industry research
-
Collaboration and engagement with the Perth Life Sciences innovation sector
-
Fast labelling of heavy data sets for further training.
-
Shortened iteration loops
-
Better clinical outcomes for patients undergoing breast conserving surgery
-
Identification of further suitable clinical applications for OncoRes’ technology
-
Deepen company understanding of the ‘burden of illness’
-
Deepen understanding of market dynamics relevant to taking a new medical device to market
FAAIZ HADI RASHEED ALSHAJALEE
Curtin University
Minerals, Energy and Chemical
Engineering
Skills: Data Science in Python/Orange and data analysis in Power BI, strong research and analytical/logical/creative thinking skills, programming skills, curiosity/willingness/desire to learn, leadership and initiative
Investing in your bones: Supporting lifelong health and performance
Singular Health Group
About
Singular Health Group (SHG) is a WA-based medical device company specialized on the visualisation of medical imaging data for medical and education purposes. SHG has experience in the creation of curriculum-aligned immersive and interactive courses on various health science topics, complemented with accurate, engaging, and pedagogic 3D/VR models. For this project, SHG has partnered with experts in the areas of bone and joint health and education. Arthritis & Osteoporosis WA is the largest organisation in WA that is dedicated to providing information, education programs, services and research with the goal of reducing the incidence and disabling effects of arthritis, osteoporosis and similar conditions in the people of WA. ECU, in particular the School of Medical and Health Sciences, under the leadership of Amanda Devine who is the Associate Dean of Public Health and OHS and Professor of Public Health Nutrition, brings extensive experience in health literacy and health education, with a focus on the role of nutrition on health and diseases.
Project
Singular Health Group, Edith Cowan University, and Arthritis and Osteoporosis WA (AOWA) are working together to research, design, promote, implement and evaluate exciting digital applications using pedagogically immersive and interactive learning experiences such as 3D and virtual reality models to increase awareness, knowledge, and motivation to address the importance of bone health for primary and secondary school students. As part of this project, students will be tasked to extensively review the resources on bone and joint health already available and used in classrooms, both in Australia and overseas. Part of these resources includes the educational material that was published and distributed by AOWA in collaboration with Osteoporosis Australia. This project includes the creation of surveys that will be distributed amongst stakeholders (teachers, students, parents, and sport coaches) with the aim of describing the resources and approaches used to raise awareness or build knowledge and practice about the importance of bone health. The information derived from this research will lead to the development of a set of design principles for immersive age-appropriate activities.
Benefits
The students who will contribute to this project will benefit from the opportunity to work with three different types of organisations, a commercial entity, a not-for-profit organisation, and an academic institution, and learn the differences underlying each of these organisations. Students will also gain a deep understanding of the health science education industry and the benefit of innovative technologies to raise awareness, build knowledge and practices to ultimately reduce the incidence of non-communicable diseases that are highly prevalent in our societies. Finally, they will contribute to the development of a set of principles that will guide the creation of the engaging resources, which will find application in Australia and overseas.
Learn More
Learn more on what we do at Singular Health at: https://singular.health
Connect with us on our social media channels: https://linktr.ee/SingularHealthGroup
More information about our immersive and curriculum-aligned courses and virtual reality experiences can be found here: https://youtu.be/7s_Vkn-PJQ4
Connect with Edith Cowan University: ECU News (@EdithCowan) / Twitter
See our website https://www.ecu.edu.au/
Arthitis and Osteoporosis WA Foundation website: https://www.arthritiswa.org.au
Development of a reference database for classification of animal health biological parameters
VetChip
About
VetChip is a West Australian company founded in 2019 by a highly experienced team of veterinarians and engineers to solve the issue of being able to detect abnormal health parameters in animals who cannot tell us when they are unwell. The initial idea was developed by veterinarian Garnett Hall who believed animals deserved a better technological solution to health prevention than the current standard set by wearable collars and trackers. Along with his brother Max, an equine veterinarian specialist, Garnett partnered with engineers Ross Khambatta, Zyrus Khambatta and Dilesh Wadia to develop the concept into a viable prototype which is in the final stages of development. The company has now grown significantly, garnering industry recognition, significant financial investment, and market validation ahead of a planned commercial rollout in 2022.
Project
Our animal health monitoring device, the ‘VetChip’, measures several biological variables. We must then analyse those variables to determine whether they are low, high or normal. There is currently no known single database that consolidates normal values and reference ranges for common species.
This project will allow us to provide a reference database that can be used to classify normal or abnormal values (including degree of abnormality) for Temperature, Heart Rate, Respiratory Rate and Tissue Oxygenation for Dogs, Cats, Horses, Cattle, Sheep and Pigs given specific biological variables (breed, sex, age and weight). This database can then be used to declare whether a reading obtained by the VetChip is normal or abnormal (including the degree of abnormality).
Benefits
Once reference database has been obtained, VetChip will enable optimal health and well-being of pets and animals, by being able to alert simultaneously pet owners and vets to any abnormal events that could indicate potential injury or illness.
Learn More